Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
NCT03575156Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Sep 2018
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Change in quantitative levels of circulating microparticles at 12 months. Started Sep 2018; status: completed.
Beyond the preview
Go deeper on NCT03575156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575156.